• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 3/15/24:Pharma Dealt Loss Over Discount Program, Adopting New Manufacturing Technologies & more


The latest news for pharma industry insiders.

Adopting New Manufacturing Technologies

A sit-down with Groovy Singh, CEO of Bright Green Corporation, who describes the waves in the global supply chain the company is making after being authorized to grow cannabis, along with cannabis-related products.

Cardiometabolic Risks in Patients With Sleep-Disordered Breathing Identified With Metabolomic Profiling

A large population-based study revealed the associations between sleep-disordered breathing (SDB) and risk for hypertension and diabetes through the use of metabolomic profiling.

Pharma dealt a loss over drug discount program

Pharmaceutical interests lost a closely watched battle over the federal drug discount program on Tuesday when a federal appeals court ruled that Arkansas can block manufacturers from limiting the availability of discounted drugs at certain pharmacies.

Microsoft to Launch AI Assistant for Security Products

Tech giant says Copilot for Security will be available worldwide next month under a pay-as-you-go licensing model

@GS1_US on Twitter/X:

GS1 US has published a new suite of resources to help companies address the requirements of the @US_FDA #FoodSafety Modernization Act #Traceability Rule (FSMA Rule 204). https://ow.ly/31rT50QSa86

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs